To examine whether iRGD induces a tumour-to-blood transport of other tumour markers in another type of tumour, we investigated the effect of iRGD on blood levels of PSA in nude mice xenografted with LNCaP prostate cancer. The gene discussed is KLK3; the disease is prostate carcinoma.